Thomas Dorner

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Mechanisms of B cell autoimmunity in SLE
    Thomas Dorner
    Charité Center 12, Department of Medicine Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum, Chariteplatz 01, 10117 Berlin, Germany
    Arthritis Res Ther 13:243. 2011
  2. ncbi SLE in 2011: Deciphering the role of NETs and networks in SLE
    Thomas Dorner
    Department of Medicine, Rheumatology and Clinical Immunology, Charité Center 12, Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum, Chariteplatz 01, 10098 Berlin, Germany
    Nat Rev Rheumatol 8:68-70. 2012
  3. ncbi Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis
    Michael F Smith
    Wyeth Research, Discovery Translational Medicine, Collegeville, PA 19426, USA
    Arthritis Res Ther 11:255. 2009
  4. ncbi Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjögren's syndrome
    Annett M Jacobi
    Department of Internal Medicine/Rheumatology and Clinical Immunology, Charite University Hospital, Berlin, Germany
    Arthritis Res 4:R4. 2002
  5. ncbi The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets
    Thomas Dorner
    Department of Rheumatology and Clinical Immunology, Charite University Hospital, Berlin, Germany
    Curr Opin Rheumatol 15:246-52. 2003
  6. ncbi Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity
    T Dorner
    Department of Transfusion Medicine, Charite University Medicine, Schumannstr 20 21, 10098 Berlin, Germany
    Clin Exp Med 4:159-69. 2005
  7. ncbi Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome
    Thomas Dorner
    Department of Medicine, Rheumatology and Clinical Immunology, University Hospital Charite, Schumannstrasse 20 21, 10098 Berlin, Germany
    Autoimmun Rev 1:119-24. 2002
  8. ncbi [Cytometric analyses in systemic autoimmune diseases]
    T Dorner
    Med Klinik m S Rheumatologie und Klin Immunologie, Charité Berlin Schumannstr 20 21 10098 Berlin, Germany
    Z Rheumatol 61:389-95. 2002
  9. ncbi Selecting B cells and plasma cells to memory
    Thomas Dorner
    University Hospital Berlin and Deutsches Rheumaforschungszentrum Berlin, 10098 Berlin, Germany
    J Exp Med 201:497-9. 2005
  10. ncbi Implant-related inflammatory arthritis
    Thomas Dorner
    Coagulation Unit, Institute of Transfusion Medicine, Charite University Medicine, Berlin, Germany
    Nat Clin Pract Rheumatol 2:53-6; quiz 57. 2006

Detail Information

Publications120 found, 100 shown here

  1. ncbi Mechanisms of B cell autoimmunity in SLE
    Thomas Dorner
    Charité Center 12, Department of Medicine Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum, Chariteplatz 01, 10117 Berlin, Germany
    Arthritis Res Ther 13:243. 2011
    ....
  2. ncbi SLE in 2011: Deciphering the role of NETs and networks in SLE
    Thomas Dorner
    Department of Medicine, Rheumatology and Clinical Immunology, Charité Center 12, Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum, Chariteplatz 01, 10098 Berlin, Germany
    Nat Rev Rheumatol 8:68-70. 2012
    ....
  3. ncbi Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis
    Michael F Smith
    Wyeth Research, Discovery Translational Medicine, Collegeville, PA 19426, USA
    Arthritis Res Ther 11:255. 2009
    ....
  4. ncbi Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjögren's syndrome
    Annett M Jacobi
    Department of Internal Medicine/Rheumatology and Clinical Immunology, Charite University Hospital, Berlin, Germany
    Arthritis Res 4:R4. 2002
    ..These results suggest a role of antigen-activated and selected B cells in the local autoimmune process in SS...
  5. ncbi The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets
    Thomas Dorner
    Department of Rheumatology and Clinical Immunology, Charite University Hospital, Berlin, Germany
    Curr Opin Rheumatol 15:246-52. 2003
    ..This review will focus on recent findings of the role of B cells in rheumatoid arthritis and the implications to target B cells in this disease...
  6. ncbi Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity
    T Dorner
    Department of Transfusion Medicine, Charite University Medicine, Schumannstr 20 21, 10098 Berlin, Germany
    Clin Exp Med 4:159-69. 2005
    ..Identification of the mechanisms that influence the IgV gene and B-cell repertoire may allow new therapeutic approaches in autoimmunity...
  7. ncbi Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome
    Thomas Dorner
    Department of Medicine, Rheumatology and Clinical Immunology, University Hospital Charite, Schumannstrasse 20 21, 10098 Berlin, Germany
    Autoimmun Rev 1:119-24. 2002
    ..The nature of the influences that lead to disordered selection in pSS remains to be determined, but should provide important clues to the etiology of this autoimmune inflammatory disorder...
  8. ncbi [Cytometric analyses in systemic autoimmune diseases]
    T Dorner
    Med Klinik m S Rheumatologie und Klin Immunologie, Charité Berlin Schumannstr 20 21 10098 Berlin, Germany
    Z Rheumatol 61:389-95. 2002
    ....
  9. ncbi Selecting B cells and plasma cells to memory
    Thomas Dorner
    University Hospital Berlin and Deutsches Rheumaforschungszentrum Berlin, 10098 Berlin, Germany
    J Exp Med 201:497-9. 2005
    ..How these differentiation pathways relate to each other, how cells are selected into these memory populations, and how these populations are maintained remains enigmatic...
  10. ncbi Implant-related inflammatory arthritis
    Thomas Dorner
    Coagulation Unit, Institute of Transfusion Medicine, Charite University Medicine, Berlin, Germany
    Nat Clin Pract Rheumatol 2:53-6; quiz 57. 2006
    ..The patient had received a wrought titanium 6-aluminium 4-vanadium alloy C cage implant 1.5 years previously, following a severe disc prolapse. No signs of rheumatic disease were evident before the C cage was implanted...
  11. ncbi B cells in autoimmunity
    Thomas Dorner
    Charite Center 12 and 14, Charite University Hospital and DRFZ Berlin, Chariteplatz 01, 10098 Berlin, Germany
    Arthritis Res Ther 11:247. 2009
    ..Based on preclinical and clinical data, B cells have emerged increasingly as both effector cells as well as cells with immunoregulatory potential...
  12. ncbi New approaches of B-cell-directed therapy: beyond rituximab
    Thomas Dorner
    Charite Center 14, Charite University Hospital Berlin, Berlin, Germany
    Curr Opin Rheumatol 20:263-8. 2008
    ..This study reviews therapeutic approaches of direct and indirect B-cell targeting in autoimmune diseases and their impact on protective immunity...
  13. ncbi Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
    Thomas Dorner
    Charité Medicine University, Berlin, Germany
    Autoimmun Rev 9:82-9. 2009
    ..However, given the lack of robust data from large randomised controlled trials, anti-CD20 therapy should be considered on an individual basis in otherwise refractory patients and its use based on a risk/benefit net calculation...
  14. ncbi Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
    Thomas Dorner
    Department of Medicine Rheumatology and Clinical Immunology, Charite Hospital, Berlin, Germany
    Arthritis Res Ther 8:R74. 2006
    ..As such, multicenter controlled studies are being conducted in broader patient populations...
  15. ncbi Significance of autoantibodies in neonatal lupus erythematosus
    T Dorner
    Department of Medicine Rheumatology and Clinical Immunology, Charite Medical School, Humboldt University, Berlin, Germany
    Int Arch Allergy Immunol 123:58-66. 2000
    ..Current knowledge about the involved autoantibody-autoantigen systems, including recent therapeutic concepts of these autoimmune syndromes, is summarized...
  16. ncbi Challenges in understanding Sjögren's syndrome - improved insights into the pathogenesis generate hope for innovative therapies?
    Thomas Dorner
    CC12, Charite Universitatsmedizin Berlin, Chariteplatz 01, 10098 Berlin, Germany
    Arthritis Res Ther 13:123. 2011
    ..Potential therapeutic targets, such as blockade of the B cell-activating factor, the role of interferon-alpha, and targeting CD22, are discussed...
  17. ncbi Signalling pathways in B cells: implications for autoimmunity
    T Dorner
    Institute of Transfusion Medicine, Charite University Medicine Berlin, Coagulation Unit, Germany
    Curr Top Microbiol Immunol 305:213-40. 2006
    ....
  18. ncbi Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
    Hans Peter Tony
    Medizinische Klinik und Poliklinik II, Universitatsklinikum Wurzburg, Klinikstr 6 8, 97070 Wurzburg, Germany
    Arthritis Res Ther 13:R75. 2011
    ....
  19. ncbi Perturbations in the impact of mutational activity on Vlambda genes in systemic lupus erythematosus
    T Dorner
    Department of Medicine, University Hospital Charite, Berlin, Germany
    Arthritis Res 3:368-74. 2001
    ..The enhanced and abnormal mutational activity along with disturbances in selection may play a role in the emergence of autoreactivity in this patient with SLE...
  20. ncbi Antibodies against protein Z and fetal loss: current perspectives
    T Dorner
    Coagulation Unit, Institute of Transfusion Medicine, Charite University Medicine Berlin, Free University and Humboldt University Berlin, Schumannstrasse 20 21, D 10098, Berlin, Germany
    Clin Exp Med 5:50-4. 2005
    ..The current diagnostic relevance and therapeutic consequences of these parameters will be discussed...
  21. ncbi B-cell-directed therapies for autoimmune disease
    Thomas Dorner
    Charite Center 12 and 14, Charité University Hospital and Deutsches Rheuma Forschungszentrum Berlin, Berlin, Germany
    Nat Rev Rheumatol 5:433-41. 2009
    ....
  22. ncbi B-cell targeting: a novel approach to immune intervention today and tomorrow
    Thomas Dorner
    Charite University Hospital Berlin and Deutsche Rheumaforschungszentrum, Chariteplatz 01, 10098 Berlin, Germany
    Expert Opin Biol Ther 7:1287-99. 2007
    ....
  23. ncbi Abnormalities of B cell subsets in patients with systemic lupus erythematosus
    Thomas Dorner
    Dept Medicine Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum, Chariteplatz 01, 10098 Berlin, Germany
    J Immunol Methods 363:187-97. 2011
    ..Together, these analyses have provided new insights on the role of B cell over-reactivity in SLE...
  24. ncbi Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population
    Berthold Hoppe
    Institute of Transfusion Medicine, Campus Benjamin Franklin, Charité Universitätsklinikum Berlin, Berlin, Germany
    Thromb Haemost 96:465-70. 2006
    ....
  25. ncbi Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells
    Daniela Frölich
    Department of Medicine, Rheumatology, and Clinical Immunology, Charite University Medicine Berlin, Germany
    J Immunol 185:3103-10. 2010
    ..These results suggest that after the fate decision to differentiate into secondary memory B cells or PCs, some committed precursors continue to proliferate and mutate their V(H) genes...
  26. ncbi Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95
    Annett M Jacobi
    Charite Universitatsmedizin Berlin, Berlin, Germany
    Arthritis Rheum 58:1762-73. 2008
    ..Focusing on CD27- B cells, this study aimed to identify abnormalities in peripheral B cell subsets in patients with SLE...
  27. ncbi Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab
    Henrik E Mei
    German Rheumatism Research Center Berlin DRFZ, Berlin, Germany
    Blood 116:5181-90. 2010
    ..These data suggest that a population of mucosal B cells is self-sufficient in adult humans and not replenished by CD20(+) B cells immigrating from blood, lymphoid tissue, or bone marrow, that is, B cells depleted by rituximab...
  28. ncbi Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study
    Berthold Hoppe
    Institute of Transfusion Medicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Germany
    Arthritis Res Ther 8:R34. 2006
    ..Quantitative or qualitative differences in previously undefined PADI4 variants between patients and controls could not be demonstrated...
  29. ncbi Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura
    Lorena Martinez-Gamboa
    Charité Center 14 for Tumor Medicine, Institute for Transfusion Medicine and Immune Hematology, Charite University Hospital, Berlin, Germany
    Clin Immunol 130:199-212. 2009
    ..Thus, the spleen plays a fundamental role in controlling peripheral memory B cell homeostasis in both AITP and HD and regulates activated CD95+ B cells in patients with AITP...
  30. ncbi Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
    Capucine Daridon
    Charite Universitatsmedizin Berlin, CC12 Dept, Medicine Rheumatology and Clinical Immunology, Chariteplatz 1, Berlin 10117, Germany
    Arthritis Res Ther 12:R204. 2010
    ..Therefore, potential effects of epratuzumab on adhesion molecule expression and the migration of B-cells have been evaluated...
  31. ncbi Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response
    Marcus Odendahl
    Department of Medicine, Charit, Humbold University, D-10117 Berlin, Germany
    Blood 105:1614-21. 2005
    ....
  32. ncbi Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
    Falk Hiepe
    Klinik m S Rheumatologie und Klin Immunologie, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin, Germany
    Nat Rev Rheumatol 7:170-8. 2011
    ..Thus, long-lived plasma cells appear to be a promising new therapeutic target...
  33. ncbi Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome
    Arne Hansen
    Department of Medicine, Outpatient Department, Charite University Hospital, Berlin, Germany
    Arthritis Rheum 52:2109-19. 2005
    ..To assess whether abnormal chemokine receptor expression and/or abnormal responsiveness to the cognate ligands might underlie some of the disturbances in B cell homeostasis characteristic of primary Sjögren's syndrome (SS)...
  34. ncbi Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome
    Arne Hansen
    Department of Medicine Outpatients Department, Charite University Hospital, Berlin, Germany
    Arthritis Rheum 50:1897-908. 2004
    ..To delineate disturbances in peripheral B cell memory in primary Sjögren's syndrome (SS)...
  35. ncbi Crossroads of B cell activation in autoimmunity: rationale of targeting B cells
    Thomas Dorner
    Charité University Hospital Berlin and the Deutsches Rheumaforschungszentrum, Berlin, Germany
    J Rheumatol Suppl 77:3-11. 2006
    ..B cell targeted therapies in human trials include an anti-B lymphocyte stimulator protein agent, belimumab; an anti-CD20 agent, rituximab; and an anti-CD22 antibody, epratuzumab...
  36. ncbi Phenotypic analysis of B-cells and plasma cells
    Henrik E Mei
    German Rheumatism Research Centre, Berlin, Germany
    Methods Mol Med 136:3-18. 2007
    ....
  37. ncbi Cryopreserved human B cells as an alternative source for single cell mRNA analysis
    Arne Hansen
    Outpatients Department of Medicine, Charite University Medicine Berlin, Germany
    Cell Tissue Bank 6:299-308. 2005
    ..However, the settings for both FACS analysis and RT-PCR should be re-evaluated for each distinct subpopulation and target mRNA of interest when analyzing post-thawed cells...
  38. ncbi Memory B and memory plasma cells
    Taketoshi Yoshida
    Charité Centre 12, Clinic for Internal Medicine, Rheumatology, Clinical Immunology, Charite University Hospital Berlin, Berlin, Germany
    Immunol Rev 237:117-39. 2010
    ..Their selective targeting will depend on a molecular understanding of their lifestyle...
  39. ncbi Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment
    Khalid Muhammad
    Medizinische Klinik II, Department of Rheumatology and Clinical Immunology, University of Wurzburg, Wurzburg, Germany
    Arthritis Rheum 60:2284-93. 2009
    ..This study was undertaken to determine whether mutational acquisition in individual B cell receptors in repopulating class-switched and non-class-switched memory B cells is affected by rituximab...
  40. ncbi Anticytokine therapy impacting on B cells in autoimmune diseases
    Capucine Daridon
    Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin and Deutsches, Rheumaforschungszentrum, Berlin 10098, Germany
    Curr Opin Rheumatol 21:205-10. 2009
    ....
  41. ncbi B-cell lymphoproliferation in chronic inflammatory rheumatic diseases
    Arne Hansen
    Outpatients Department of Medicine, Charite University Hospital, Berlin, Germany
    Nat Clin Pract Rheumatol 3:561-9. 2007
    ..This Review will focus on the risk of lymphoma, common and disease-specific mechanisms of B-cell lymphoma development, and on the clinical consequences of lymphoma in patients with inflammatory rheumatic diseases...
  42. ncbi Kitasato symposium 2009: new prospects for cytokine inhibition
    Gerd R Burmester
    CC12, Charite Universitatsmedizin Berlin, Chariteplatz 01, 10098 Berlin, Germany
    Arthritis Res Ther 11:301. 2009
    ..The involvement of cytokines in other autoimmune diseases was also addressed...
  43. ncbi Blood-borne human plasma cells in steady state are derived from mucosal immune responses
    Henrik E Mei
    Center for Tumor Medicine, Institute of Transfusion Medicine, Charite University Hospital, Berlin, Germany
    Blood 113:2461-9. 2009
    ..Systemic vaccination does not impact on peripheral IgA(+) plasmablast numbers, indicating that mucosal and systemic humoral immune responses are regulated independent of each other...
  44. ncbi Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function
    Velia Gerl
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Ann Rheum Dis 69:1370-7. 2010
    ..Reduced numbers of blood DCs and the accumulation of DCs at inflammatory sites have been observed in SLE. One crucial feature of DCs is their ability to migrate...
  45. ncbi Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers
    Thomas Dorner
    Charité Center 12, Dept Rheumatology and Clinical Immunology, Charité University Hospital Berlin and Deutsches Rheumaforschungszentrum, Berlin, Germany
    Pharmacol Ther 125:464-75. 2010
    ..In patients with systemic lupus erythematosus, Fc receptors and levels of circulating immune cells (including B cells and natural killer cells) may be relevant markers...
  46. ncbi Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome
    Arne Hansen
    University Hospital Charit, Berlin, Germany
    Arthritis Rheum 46:2160-71. 2002
    ..It is possible that preferential accumulation of CD27+ memory B cells in the inflamed parotid gland explains their reduction in the peripheral blood...
  47. ncbi Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus
    Annett M Jacobi
    University Hospital Charit, Berlin, Germany
    Arthritis Rheum 48:1332-42. 2003
    ....
  48. ncbi B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue
    Arne Hansen
    Charite Center CC 12, Department of Medicine, Charite Universitatsmedizin Berlin, Charité Platz 01, 10098 Berlin, Germany
    Arthritis Res Ther 9:218. 2007
    ..These findings add to our understanding of the pathogenesis of this autoimmune inflammatory disorder and may result in new therapeutic approaches...
  49. ncbi Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus
    Maren Henneken
    Deutsches Rheuma ForschungsZentrum, Berlin, Germany
    Arthritis Res Ther 7:R1001-13. 2005
    ..However, differences between patients with RA and patients with SLE point toward a disease-specific regulation of receptor expression. These differences may influence the migrational behavior of B cells...
  50. ncbi High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura
    Florian Emmerich
    Institute for Transfusion Medicine, Charite University Medicine Berlin, Berlin, Germany
    Br J Haematol 136:309-14. 2007
    ..This promoter variant was associated with very high BAFF levels in ITP patients. Our data suggest that BAFF is an important pathogenetic factor in the development of ITP...
  51. ncbi The role of long-lived plasma cells in autoimmunity
    Sergio Arce
    German Rheumatism Research Center, Berlin, Germany
    Immunobiology 206:558-62. 2002
    ..Here, we discuss the potential involvement of long-lived plasma cells in the pathogenesis of autoimmune disease and the consequences it has for the development of effective therapeutic strategies...
  52. ncbi Patient-tailored therapy in rheumatoid arthritis: an editorial review
    Hans U Scherer
    Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Germany
    Curr Opin Rheumatol 22:237-45. 2010
    ..Such personalized, patient-tailored therapy is still not a reality in rheumatology practice. However, several important steps have recently been made towards achievement of this important goal...
  53. ncbi What do we know about memory B cells in primary Sjögren's syndrome?
    Arne Hansen
    Department of Medicine, Park Klinik Weissensee, Berlin, Germany
    Autoimmun Rev 9:600-3. 2010
    ..Thus, B cells may be potential targets of direct or indirect treatment in pSS...
  54. ncbi Use of heparin in women with early and late miscarriages with and without thrombophilia
    Silke Monien
    Department of Hemostaseology, Institute of Transfusion Medicine, Charite University Hospital Berlin, Berlin, Germany
    Clin Appl Thromb Hemost 15:636-44. 2009
    ..Because of the fact that heparin has both anticoagulative and anti-inflammatory effects, the current study evaluated the efficacy of low-molecular-weight heparin (LMWH) in unexplained abortions...
  55. ncbi Rapid detection of autoantibodies to dsDNA with the particle gel immunoassay (ID-PaGIA)
    A Seltsam
    Institute of Transfusion Medicine, , Humboldt University Berlin, Germany
    Ann Rheum Dis 61:367-9. 2002
    ..81, p<0.0001) and ELISA (r=0.73, p<0.0001). CONCLUSIONS: The new particle gel agglutination test is a sensitive and specific immunoassay. It is a simple test procedure that might be well suited as a rapid screening method...
  56. ncbi B*4440: a novel HLA-B allele identified by sequence-specific oligonucleotide hybridization and sequence-specific amplification
    G A Heymann
    Institute of Transfusion Medicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    Tissue Antigens 65:195-8. 2005
    ..DNA sequencing confirmed a variation of codons 44 and 45 (AGG AAG-->AGA GAG) and codon 50 (CCA-->CCG), resulting in an amino acid substitution Lys-->Glu at codon 45...
  57. ncbi Kitasato Symposium 2010: new prospects for cytokines
    Gerd R Burmester
    CC12, Charite Universitatsmedizin Berlin, Chariteplatz 01, 10098 Berlin, Germany
    Arthritis Res Ther 12:301. 2010
    ..The presentations at the Symposium resulted in productive discussions regarding potential new targets for the treatment of rheumatoid arthritis and other autoimmune disorders...
  58. ncbi Developments in lupus 2006
    Arne Hansen
    Charite Centrum 12, Charite University Medicine, Chariteplatz 01, 10098 Berlin, Germany
    Arthritis Res Ther 9:215. 2007
    ..Although it remains to be shown which of those could be targets for therapy or biomarkers, lymphocyte-directed therapy is currently under promising clinical investigation...
  59. ncbi Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Augustenburger Platz 01, 13555 Berlin, Germany
    Arthritis Res Ther 13:R118. 2011
    ..Diagnosis of antiphospholipid syndrome (APS) still remains a laboratory challenge due to the great diversity of antiphospholipid antibodies (aPL) and their significance regarding APS-diagnostic criteria...
  60. ncbi Antibodies and B cell memory in viral immunity
    Thomas Dorner
    Charite Universitätsmedizin Berlin and Deutsches Rheumaforschungszentrum Berlin, 10117 Berlin, Germany
    Immunity 27:384-92. 2007
    ..e., HIV) have managed to develop specific evasion strategies to escape it. Thus, coevolution provides us with some insight into just how substantial antiviral antibodies and memory B cell are in protecting the host from virus infection...
  61. ncbi Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy
    Arne Hansen
    Charite University Medicine Berlin, Germany
    Curr Opin Rheumatol 17:558-65. 2005
    ..This review highlights recent advances in understanding the underlying mechanisms of the disease as well as their implications for clinical handling and therapeutic options...
  62. ncbi Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome
    Thomas Dorner
    Department of Medicine, Rheumatology and Clinical Immunology, University Hospital Charite, Berlin, Germany
    Arthritis Res 4:360-71. 2002
    ..Because disordered selection leads to considerable differences in the B cell repertoire in these patients, the delineation of its nature should provide important further clues to the pathogenesis of this autoimmune inflammatory disorder...
  63. ncbi [B-cell depletion in the treatment of rheumatoid arthritis]
    Eugen Feist
    Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Universitätsklinikum Charité Humboldt Universität zu Berlin, Berlin, Germany
    Z Rheumatol 62:361-6. 2003
    ..Here, we discuss recent data of a temporary B cell depletion using a monoclonal anti-CD20 antibody in the therapeutic arsenal of rheumatoid arthritis...
  64. ncbi Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism
    Berthold Hoppe
    Institutee of Transfusion Meidicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    Blood 105:1549-51. 2005
    ..3%). Logistic regression analysis confirmed FSAP Marburg I to be an independent risk factor for VTE (odds ratio, 3.5; 95% confidence interval [CI], 1.2-10.0) and idiopathic VTE (odds ratio, 6.2; 95% CI, 2.0-18.9)...
  65. ncbi Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjögren's syndrome
    Arne Stroehmann
    Department of Anaesthesiology and Intensive Care Medicine, Charite University Hospital, Humboldt University, Berlin, Germany
    J Rheumatol 29:1326-9. 2002
    ..There are few reports of T cell lymphoma in primary SS. The occurrence of a T cell lymphoma in a patient with PBC and secondary SS indicates the necessity to investigate lymphoma in patients with secondary SS...
  66. ncbi Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield
    M Hildebrandt
    Departments of Internal Medicine Blood Bank and Pediatrics, Charite, Campus Virchow Klinikum, Humboldt University, Berlin, Germany
    Transfusion 40:507-12. 2000
    ..In immunomagnetic selection of CD34+ cells from HPC transplants, not all factors that affect yield and purity of CD34+ cells are known...
  67. ncbi Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease
    M Hildebrandt
    Dept of Psychosomatic Medicine, Humboldt Universitat zu Berlin, Germany
    Scand J Gastroenterol 36:1067-72. 2001
    ..We hypothesized that the activity of DP IV in serum and expression of CD26/DP IV in lymphocytes may be altered in patients with inflammatory bowel disease (IBD)...
  68. ncbi Identification of a novel HLA-B allele, HLA-B*5529, by haplotype-specific sequencing
    F Emmerich
    Center for Tumor Medicine, Institute for Transfusion Medicine, Charite University Medicine, Berlin, Germany
    Tissue Antigens 71:486. 2008
    ..Thus, the newly found allele is estimated to have a low alloreactive potential in case of a mismatch to the most common HLA-B allele B*5501...
  69. ncbi Detection of a new weak A blood-group allele (Aw11)
    A Pruss
    Institute of Transfusion Medicine Universitätsmedizin Berlin, Berlin, Germany
    Vox Sang 90:195-7. 2006
    ..Weak ABO variants may escape tests using unlicensed sera...
  70. ncbi Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment
    N Ahrens
    Institute for Transfusion Medicine, Charite University Medicine Berlin, Germany
    Clin Exp Immunol 151:455-8. 2008
    ..Most importantly, IgA appears to play an important role in the treatment of CVID. Patients with IgA anaphylactoid reactions can be treated safely with IgA containing i.v. IgG preparations following tolerance induction...
  71. ncbi Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature
    A Salama
    Institut fur Transfusionsmedizin, Charite Universitatsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    Ann Hematol 88:11-5. 2009
    ..The results indicate that rFVIIa may help in the emergency treatment of patients with ITP who do not respond to other therapies...
  72. ncbi A novel HLA-A*680104 variant
    G A Heymann
    Institute of Transfusion Medicine, Campus Virchow-Klinikum, , Berlin, Germany
    Tissue Antigens 67:169-70. 2006
  73. ncbi [Aquired immune hemolytic anemias]
    A Salama
    Medizinische Fakultät der Humboldt Universität, Institut für Bluttransfusionen, Campus Virchow Klinikum, Charite, Berlin
    Ther Umsch 61:178-86. 2004
    ..The true incidence of alloimmune hemolytic anemias including neonatal immune hemolytic anemias is unknown. The paroxysmal nocturnal hemoglobinuria is rare. It is caused by complement activation due to aquired membrane defects...
  74. ncbi A novel HLA-B*270509 variant escaping detection by PCR-SSO-based histotyping
    G A Heymann
    Institute of Transfusion Medicine, Campus Virchow-Klinikum, , Augustenburger Platz 1, 13353 Berlin, Germany
    Tissue Antigens 66:702-3. 2005
  75. ncbi Identification and characterization of a novel HLA-DRB1 allele, DRB1*0830*
    B Hoppe
    Institute of Transfusion Medicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Berlin, Germany
    Tissue Antigens 66:160-2. 2005
    ..Allele-specific DNA sequencing confirmed a 286 T-->A substitution resulting in Phe67Ile...
  76. ncbi Haplotype-specific sequencing reveals a novel HLA-B*37 allele, B*3714
    F Emmerich
    Center for Tumor Medicine, Institute for Transfusion Medicine, Charite University Medicine, Berlin, Germany
    Tissue Antigens 73:67. 2009
    ..The first one leads to the exchange from arginine to leucine at position 82, and the latter one from glycine to arginine at position 83...
  77. ncbi Immune hemolysis-serological and clinical aspects
    A Pruss
    Institute for Transfusion Medicine, University Hospital Charite, Medical Faculty of the Humboldt University of Berlin, Schumannstrasse 20 21, 10117 Berlin, Germany
    Clin Exp Med 3:55-64. 2003
    ..Finally, current and partly experimental therapeutic strategies of immune hemolytic anemias are summarized...
  78. ncbi Influence of blood donation on levels of water-soluble vitamins
    U Kalus
    Institute of Transfusion Medicine, Charite University Medicine Berlin, Berlin, Germany
    Transfus Med 18:360-5. 2008
    ..Blood donation does not decrease the level of water-soluble vitamins. Vitamin deficiencies occur in apparently healthy first-time as well as in repeat blood donors and can be prevented by vitamin supplementation...
  79. ncbi Identification of the novel HLA-A*240215 allele by haplotype-specific sequencing
    F Emmerich
    Center for Tumor Medicine, Institute for Transfusion Medicine, Charite University Medicine, Berlin, Germany
    Tissue Antigens 71:481-2. 2008
    ..Here, we report on a novel allele human leukocyte antigen (HLA)-A*240215. This allele differs from HLA-A*240201 by a synonymous nucleotide exchange at nucleotide 255 in exon 2...
  80. ncbi Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis
    B Hoppe
    Central Institute of Laboratory Medicine and Pathobiochemistry, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Germany
    Ann Rheum Dis 68:898-903. 2009
    ..HLA-DRB1 shared epitope (SE) and peptidylarginine deiminase type 4 (PADI4) genotype, both of which have been implicated in anti-CCP generation, are assumed to be associated with RA...
  81. ncbi Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication
    N Ahrens
    Institute for Transfusion Medicine, Charite University Medicine Berlin, Germany
    Vox Sang 86:71-4. 2004
    ..A relationship with oral or intramuscular drug administration is unknown. Here, we describe a patient who apparently tolerated oral diclofenac but developed severe IHA following intramuscular injection of the drug...
  82. ncbi Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome
    M Hildebrandt
    Department of Internal Medicine, Humboldt Universitat zu Berlin, Germany
    Clin Cancer Res 6:4641-6. 2000
    ..The presence of contaminating tumor cells in PBPC harvests of patients with germ-cell tumors seems to predict a poor overall and event-free survival in patients undergoing HDCT and autologous PBPC reinfusion...
  83. ncbi Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay
    A Salama
    Blood Bank, Charite, Campus Virchow Clinic, Berlin, Germany
    Vox Sang 81:45-8. 2001
    ..Antibodies to immunoglobulin A (IgA) molecules are thought to be frequently responsible for anaphylactic reactions in transfusion medicine, but practical tests for the detection of antibodies to IgA are not yet available...
  84. ncbi Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells
    A Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Germany
    Stem Cells 22:283-91. 2004
    ..This finding correlates with increased Ad capping at the cell surface and suggests an alteration of Ad trafficking...
  85. ncbi Description of a novel HLA-B allele, B*5613, identified during HLA-typing using sequence-specific oligonucleotide hybridization and sequence-specific amplification
    B Hoppe
    Institute of Transfusion Medicine, Campus Virchow Klinikum, Charite Universitatsmedizin Berlin, Germany
    Tissue Antigens 64:616-8. 2004
    ..DNA sequencing confirmed a variation of codon 180 (CTG-->GAC) resulting in an amino acid substitution Leu156Asp...
  86. ncbi Immunoadsorption patients with multiple sclerosis: an open-label pilot study
    A Moldenhauer
    Charite Universitatsmedizin Berlin, Germany
    Eur J Clin Invest 35:523-30. 2005
    ..This pilot study was undertaken to determine whether IA might help in secondary progressive and relapsing-remitting multiple sclerosis...
  87. ncbi ELISA methods detect HLA antibodies with variable sensitivity
    S Monien
    Tissue Typing Laboratory, Institute of Transfusion Medicine, Charite, University Hospital Berlin, Germany
    Int J Immunogenet 33:163-6. 2006
    ..5% and 98.4% (LAT-M) vs. 88.3% and 95.5% (AbScreen). These results indicate that a single ELISA does not invariably prove or exclude the presence of HLA antibodies, and that additional testing is required in some cases...
  88. ncbi Optimum storage conditions for cord blood-derived hematopoietic progenitor cells prior to isolation
    A Moldenhauer
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Bone Marrow Transplant 40:837-42. 2007
    ..CD34+ cells kept at RT for 48 h had the highest transmigration capacities, which paralleled an increased CXCR-4 expression. Cord blood should be stored at RT before CD34+ isolation and a storage time for 48 h should be preferred to 24 h...
  89. ncbi A novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping
    O Meyer
    Charit, , , Berlin, Germany
    Vox Sang 91:324-30. 2006
    ..CONCLUSION: In our opinion, the ASCA is easy to perform and much more sensitive than the currently available antigen-specific assays for the detection of platelet antibodies...
  90. ncbi [Preoperative identification of patients with impaired (primary) haemostasis. A practical concept]
    J Koscielny
    Universitatsmedizin Berlin, Charite, Institut für Transfusionmedizin, Gerinnungsambulanz, Campus Charite Mitte, Chariteplatz 1, 10117 Berlin
    Hamostaseologie 27:177-84. 2007
    ..Based on these data, national regards are formulated or under construction...
  91. ncbi Identification of a novel HLA-DQB1 allele, HLA-DQB1*0632
    F Emmerich
    Center for Tumor Medicine, Institute for Transfusion Medicine, Charite University Medicine, Berlin, Germany
    Tissue Antigens 71:94-5. 2008
    ..DQB1*0632 differs from DQB1*0603 by one nucleotide change in exon 2 resulting in the amino acid exchange Gly --> Arg...
  92. ncbi Application of the particle gel agglutination system as a new check gel assay for PCR products
    C Schonemann
    Institute of Transfusion Medicine, Charite University Medicine Berlin, Berlin, Germany
    Int J Immunogenet 34:337-9. 2007
    ..The results obtained by the new test were in accordance with those obtained by standard gel electrophoresis in all cases that have been tested to date...
  93. ncbi CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia
    N Ahrens
    Institute for Transfusion Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany
    Transfus Med 16:397-402. 2006
    ..Similarly, CD47 was detectable in the plasma of the studied subjects. No evidence for a pathogenetic role of CD47 in autoimmune haemolysis or thrombocytopenia in humans could be demonstrated...
  94. ncbi Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus
    Andreas Hutloff
    Robert Koch Institute, Berlin, Germany
    Arthritis Rheum 50:3211-20. 2004
    ..Furthermore, our identification of plasma cells in areas of T cell-B cell interaction in kidneys suggests that components of a T cell-driven B cell activation process may take place in peripheral tissues in SLE...
  95. ncbi Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Institute of Biochemistry, Humboldt University of Berlin, Berlin, Germany
    J Rheumatol 29:2045-52. 2002
    ..The cProteasomes represent novel sensitive markers of the autoimmune inflammatory processes and/or reflect the magnitude of cellular damage...
  96. ncbi Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells
    Sarka Ruzickova
    Deutsches Rheumaforschungszentrum, Berlin, Germany
    Blood 100:3419-22. 2002
    ..Of note, our findings suggest that this B-CLL had developed from the patient's CA-producing B-cell population...
  97. ncbi Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
    Anne Sophie Rouzière
    Department of Medicine II, Rheumatology and Clinical Immunology, University of Wuerzburg, Germany
    Arthritis Res Ther 7:R714-24. 2005
    ..The longitudinal observation of a single patient up to 27 months shows subtle intraindividual changes, which may indicate repertoire modulation...
  98. ncbi Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome)
    Berthold Hoppe
    Institute of Laboratory Medicine and Pathobiochemistry, Charite Universitatsmedizin Berlin, Germany
    Curr Opin Rheumatol 23:299-304. 2011
    ..The aim of this review is to summarize current knowledge on pathogenesis of miscarriage in APS and the impact of different antithrombotic therapy strategies...
  99. ncbi New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers
    Arne Hansen
    Charite University Hospital, Berlin, Germany
    Curr Opin Rheumatol 15:563-70. 2003
    ..As demonstrated by the introduction of the new targeted therapeutic approaches in rheumatoid arthritis, solid insights into the pathogenesis of Sjögren syndrome may pave the way toward new therapeutic approaches...